ALB and neoplasm: In addition, the intratumoral injection of the albumin-stabilized CeO2 NPs led to contrast enhancements at the tumor site for up to 7 days after injection, and 99% of the injected dose remained at the tumor site, allowing for the monitoring of tumor growth and dynamics.